nach oben

Hepatology International

Erschienen in:

04.10.2019 | Editorial

Refining the role of epicardial adipose tissue in non-alcoholic fatty liver disease

verfasst von: Mohammed Eslam, Jacob George

Erschienen in: Hepatology International | Ausgabe 6/2019

Einloggen, um Zugang zu erhalten

Excerpt

Obesity is a rapidly growing public health challenge, with global prevalence having increased substantially over four decades, from less than 3% and 6% in 1975, to 11% and 15% in 2016, among male and female, respectively [1]. This development, together with concomitant increases in diabetes, has fuelled a dramatic escalation in the prevalence of non-alcoholic fatty liver disease (NAFLD). NAFLD is now a leading cause of chronic liver disease, and afflicts about a quarter of the global population [2]. …

Jaacks LM, Vandevijvere S, Pan A, McGowan CJ, Wallace C, Imamura F, et al. The obesity transition: stages of the global epidemic. Lancet Diabetes Endocrinol 2019;7:231–240CrossRef

Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol 2018;15:11–20CrossRef

van der Poorten D, Milner KL, Hui J, Hodge A, Trenell MI, Kench JG, et al. Visceral fat: a key mediator of steatohepatitis in metabolic liver disease. Hepatology 2008;48:449–457CrossRef

Perseghin G. Lipids in the wrong place: visceral fat and nonalcoholic steatohepatitis. Diabetes Care 2011;34(Suppl 2):S367–S370CrossRef

Mazurek T, Zhang LF, Zalewski A, Mannion JD, Diehl JT, Arafat H, et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 2003;108:2460–2466CrossRef

Jermendy AL, Kolossvary M, Drobni ZD, Tarnoki AD, Tarnoki DL, Karady J, et al. Assessing genetic and environmental influences on epicardial and abdominal adipose tissue quantities: a classical twin study. Int J Obes 2018;42:163–168CrossRef

El-Khoudary SR, Shin C, Masaki K, Miura K, Budoff M, Edmundowicz D, et al. Ectopic cardiovascular fat in middle-aged men: effects of race/ethnicity, overall and central adiposity: the ERA JUMP study. Int J Obes 2015;39:488–494CrossRef

Adams DB, Narayan O, Munnur RK, Cameron JD, Wong DTL, Talman AH, et al. Ethnic differences in coronary plaque and epicardial fat volume quantified using computed tomography. Int J Cardiovasc Imaging 2017;33:241–249CrossRef

Li YR, Liu B, Li Y, Jing XD, Deng SB, Yan YL, et al. Epicardial fat tissue in patients with diabetes mellitus: a systematic review and meta-analysis. Cardiovasc Diabetol 2019;18:3CrossRef

10.

Jeong JW, Jeong MH, Yun KH, Oh SK, Park EM, Kim YK, et al. Echocardiographic epicardial fat thickness and coronary artery disease. Circ J 2007;71:536–539CrossRef

11.

Marchington JM, Mattacks CA, Pond CM. Adipose-tissue in the mammalian heart and pericardium—structure, fetal development and biochemical-properties. Comp Biochem Physiol B Biochem Mol Biol 1989;94:225–232CrossRef

12.

Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A, et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005;129:113–121CrossRef

13.

Vilar-Gomez E, Calzadilla-Bertot L, Wong VWS, Castellanos M, Aller-de-la-Fuente R, Metwally M, et al. Fibrosis severity as a determinant of cause-specific mortality in patients with advanced nonalcoholic fatty liver disease: a multi-national cohort study. Gastroenterology 2018;155:443CrossRef

14.

Psychari SN, Rekleiti N, Papaioannou N, Varhalama E, Drakoulis C, Apostolou TS, et al. Epicardial fat in nonalcoholic fatty liver disease: properties and relationships with metabolic factors, cardiac structure, and cardiac function. Angiology 2016;67:41–48CrossRef

15.

Brouha SS, Nguyen P, Bettencourt R, Sirlin CB, Loomba R. Increased severity of liver fat content and liver fibrosis in non-alcoholic fatty liver disease correlate with epicardial fat volume in type 2 diabetes: a prospective study. Eur Radiol 2018;28:1345–1355CrossRef

16.

Liu B et al. Association of epicardial adipose tissue with non-alcoholic fatty liver disease: a meta-analysis. Hepatol Int 2019. https://doi.org/10.1007/s12072-019-09972-1 CrossRefPubMedPubMedCentral

17.

Villarroya F, Gavalda-Navarro A, Peyrou M, Villarroya J, Giralt M. The lives and times of brown adipokines. Trends Endocrinol Metab 2017;28:855–867CrossRef

18.

Kabir M, Catalano KJ, Ananthnarayan S, Kim SP, Van Citters GW, Dea MK, et al. Molecular evidence supporting the portal theory: a causative link between visceral adiposity and hepatic insulin resistance. Am J Physiol Endocrinol Metab 2005;288:E454–E461CrossRef

19.

Christensen RH, Wedell-Neergaard AS, Lehrskov LL, Legaard GE, Dorph E, Larsen MK, et al. Effect of aerobic and resistance exercise on cardiac adipose tissues: secondary analyses from a randomized clinical trial. JAMA Cardiol 2019;8:778–787CrossRef

20.

Dutour A, Abdesselam I, Ancel P, Kober F, Mrad G, Darmon P, et al. Exenatide decreases liver fat content and epicardial adipose tissue in patients with obesity and type 2 diabetes: a prospective randomized clinical trial using magnetic resonance imaging and spectroscopy. Diabetes Obes Metab 2016;18:882–891CrossRef

21.

Iacobellis G, Mohseni M, Bianco SD, Banga PK. Liraglutide causes large and rapid epicardial fat reduction. Obesity 2017;25:311–316CrossRef

22.

Alexopoulos N, Melek BH, Arepalli CD, Hartlage GR, Chen ZJ, Kim S, et al. Effect of intensive versus moderate lipid-lowering therapy on epicardial adipose tissue in hyperlipidemic post-menopausal women a substudy of the BELLES trial (beyond endorsed lipid lowering with EBT scanning). J Am Coll Cardiol 2013;61:1956–1961CrossRef

23.

Willens HJ, Byers P, Chirinos JA, Labrador E, Hare JM, de Marchena E. Effects of weight loss after bariatric surgery on epicardial fat measured using echocardiography. Am J Cardiol 2007;99:1242–1245CrossRef

Titel: Refining the role of epicardial adipose tissue in non-alcoholic fatty liver disease
verfasst von: Mohammed Eslam
Jacob George
Publikationsdatum: 04.10.2019
Verlag: Springer India
Erschienen in: Hepatology International / Ausgabe 6/2019
Print ISSN: 1936-0533
Elektronische ISSN: 1936-0541
DOI: https://doi.org/10.1007/s12072-019-09990-z

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

24.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Refining the role of epicardial adipose tissue in non-alcoholic fatty liver disease

Excerpt

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Metformin rückt in den Hintergrund

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Thrombophiliescreening – Wenn, dann richtig und nur bei therapeutischer Konsequenz

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Update Innere Medizin

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2019

Hepatocellular carcinoma and non-alcoholic fatty liver disease

Sarcopenia and fatty liver disease

Correction to: Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update

Significant decrease in Faecalibacterium among gut microbiota in nonalcoholic fatty liver disease: a large BMI- and sex-matched population study

Treatment with carvedilol improves survival of patients with acute-on-chronic liver failure: a randomized controlled trial

Circulating tumor cells are associated with poor outcomes in early-stage hepatocellular carcinoma: a prospective study

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Metformin rückt in den Hintergrund

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Thrombophiliescreening – Wenn, dann richtig und nur bei therapeutischer Konsequenz

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Update Innere Medizin